Free Trial

Genus (LON:GNS) Given New GBX 2,900 Price Target at Shore Capital

Genus logo with Medical background

Key Points

  • Shore Capital has increased the price target for Genus (LON:GNS) from GBX 2,630 to GBX 2,900, indicating a potential upside of 7.17% from its current price.
  • Deutsche Bank also raised its price target for Genus to GBX 2,550, maintaining a "buy" rating on the stock.
  • Genus has a current market cap of £1.77 billion, and operates in animal genetics across multiple global regions.
  • Interested in Genus? Here are five stocks we like better.

Genus (LON:GNS - Get Free Report) had its target price hoisted by stock analysts at Shore Capital from GBX 2,630 to GBX 2,900 in a report issued on Thursday, Marketbeat.com reports. The brokerage currently has a "buy" rating on the stock. Shore Capital's price target would indicate a potential upside of 8.41% from the company's previous close.

Separately, Deutsche Bank Aktiengesellschaft increased their target price on Genus from GBX 2,250 to GBX 2,550 and gave the stock a "buy" rating in a report on Tuesday, July 15th. Two analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of GBX 2,725.

Get Our Latest Stock Report on Genus

Genus Trading Down 0.6%

Genus stock traded down GBX 15 during mid-day trading on Thursday, hitting GBX 2,675. 167,138 shares of the company's stock were exchanged, compared to its average volume of 224,858. The firm has a market capitalization of £1.75 billion, a P/E ratio of 221.73, a PEG ratio of 2.87 and a beta of 0.37. Genus has a fifty-two week low of GBX 1,424 and a fifty-two week high of GBX 2,760. The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.12. The company's 50 day simple moving average is GBX 2,332.14 and its 200-day simple moving average is GBX 2,036.29.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

See Also

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.